JPRN-UMIN000036772已完成未知
JAPANESE PROSPECTIVE REAL WORLD REGISTRY OF NIVOLUMAB PLUS IPILIMUMAB IN SUBJECTS WITH PREVIOUSLY UNTREATED, ADVANCED OR METASTATIC RENAL CELL CARCINOMA (ARCC) CATEGORIZED INTO IMDC INTERMEDIATE/POOR RISKS (J-ENCORE) - J-ENCORE
Bristol-Myers Squibb K.K. Ono Pharmaceutical CO.,LTD.0 个研究点目标入组 286 人开始时间: 2019年5月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 286
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. combination therapy in Japan 2. Pregnant and/or lactating women 3. Patients who are judged to be inappropriate by investigator
研究者
相似试验
招募中
Unknown
JAPANESE PROSPECTIVE REAL WORLD REGISTRY OF CABOZANTINIB PLUS NIVOLUMABIN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED OR METASTATIC RENAL CELL CARCINOMAadvanced or metastatic renal cell carcinomaJPRN-UMIN000052855Kinki University50
招募中
Unknown
JAPANESE PROSPECTIVE REAL WORLD REGISTRY OF CABOZANTINIB PLUS NIVOLUMABIN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED OR METASTATIC RENAL CELL CARCINOMAadvanced or metastatic renal cell carcinomaJPRN-UMIN000050778Kindai University School of Medicine200
尚未招募
Unknown
Japanese National RegistryPKD(JRP)autosomal dominant polycystic kidney disease, autosomal recessive polycystic kidney diseaseJPRN-jRCT1030230618Muto Satoru1,100
招募中
不适用
Establishment of Japanese-originated comprehensive biomarker system for diagnosis and stratification of patients with various types of dementias based on multicenter alliance for brain biomarkers (MABB)Mild cognitive impairmentJPRN-UMIN000047214Japan Agency for Medical Research and Development240
招募中
Unknown
Japanese Normative Database ProjectJPRN-jRCT1090220310Yoshihito Shigihara120